The current study was conducted to investigate whether patients with familial combined hyperlipidaemia (FCHL ) are predisposed to the development of type 2 diabetes mellitus (T2DM).
Departments of Medicine and Endocrinology, Laboratory of Vascular Medicine and Metabolism, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, the Netherlands. Martijn.brouwers@intmed.unimaas.nl